Ameet Mallik

Ameet Mallik is an accomplished leader in the biotechnology and pharmaceutical industries, currently serving as President and CEO of ADC Therapeutics since May 2022. In addition to this role, Ameet is a board member for NJ LEEP and Atara Biotherapeutics, and serves as a Strategic Advisor for Juvena Therapeutics. Ameet has held significant positions at Novartis Oncology, including Executive Vice President and Head of U.S., with responsibilities for comprehensive commercial and medical operations. Earlier roles include leadership at Novartis, McKinsey & Company, and Abbott, complemented by an extensive educational background with an MBA from The Wharton School and degrees in Biotechnology and Chemical Engineering from Northwestern University.